NCT01710852View on ClinicalTrials.gov

Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DRUG

ISIS CRP Rx

DRUG

Placebo

Trial Locations (1)

BN21 2UD

Eastbourne General Hospital - Cardiology Department, Eastbourne

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY